Joong Sup Shim
Affiliations: | University of Macau |
Google:
"Joong Shim"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Tao S, Yang EJ, Zong G, et al. (2023) ER translocon inhibitor ipomoeassin F inhibits triple-negative breast cancer growth via blocking ER molecular chaperones. International Journal of Biological Sciences. 19: 4020-4035 |
Wang X, Huang J, Liu F, et al. (2023) Aurora A kinase inhibition elevates PD-L1 expression and compromises its anti-tumor efficacy. The Journal of Clinical Investigation |
Shi C, Tao S, Ren G, et al. (2022) Aurora kinase A inhibition induces synthetic lethality in SMAD4-deficient colorectal cancer cells via spindle assembly checkpoint activation. Oncogene |
Zhang L, Chen C, Fu J, et al. (2021) Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa. Elife. 10 |
Shi C, Yang EJ, Liu Y, et al. (2020) Bromodomain and extra-terminal motif (BET) inhibition is synthetic lethal with loss of SMAD4 in colorectal cancer cells via restoring the loss of MYC repression. Oncogene |
Hwang HY, Shim JS, Kim D, et al. (2020) Antidepressant drug sertraline modulates AMPK-MTOR signaling-mediated autophagy via targeting mitochondrial VDAC1 protein. Autophagy |
Liu Y, Yang EJ, Shi C, et al. (2020) Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT. International Journal of Biological Sciences. 16: 1774-1784 |
Zhang B, Lyu J, Yang EJ, et al. (2020) Class I histone deacetylase inhibition is synthetic lethal with BRCA1 deficiency in breast cancer cells. Acta Pharmaceutica Sinica. B. 10: 615-627 |
Lyu J, Yang EJ, Shim JS. (2019) Cholesterol Trafficking: An Emerging Therapeutic Target for Angiogenesis and Cancer. Cells. 8 |
Lyu J, Yang EJ, Head SA, et al. (2018) Astemizole Inhibits mTOR Signaling and Angiogenesis by Blocking Cholesterol Trafficking. International Journal of Biological Sciences. 14: 1175-1185 |